160
Views
3
CrossRef citations to date
0
Altmetric
OSTEOPOROSIS

PERK activator CCT020312 prevents inflammation-mediated osteoporosis in the ovariectomized rats

, &
Pages 342-348 | Received 19 Oct 2020, Accepted 08 Jan 2021, Published online: 22 Jan 2021

References

  • Zhang T, Zhao K, Han W, et al. Deguelin inhibits RANKL-induced osteoclastogenesis in vitro and prevents inflammation-mediated bone loss in vivo. J Cell Physiol. 2019;234(3):2719–2729.
  • Orsal E, Halici Z, Bayir Y, et al. The role of carnitine on ovariectomy and inflammation-induced osteoporosis in rats. Exp Biol Med. 2013;238(12):1406–1412.
  • Son HS, Lee J, Lee HI, et al. Benzydamine inhibits osteoclast differentiation and bone resorption via down-regulation of interleukin-1 β expression. Acta Pharm Sin B. 2020;10(3):462–474.
  • Lin TH, Yang RS, Wang KC, et al. Ethanol extracts of fresh Davallia formosana (WL1101) inhibit osteoclast differentiation by suppressing RANKL-induced nuclear factor-κB activation. Evid Based Complement Alternat Med. 2013;2013:647189.
  • Carbonel AAF, Vieira MC, Simoes RS, et al. Isoflavones improve collagen I and glycosaminoglycans and prevent bone loss in type 1 diabetic rats. Climacteric: J Int Menopause Soc. 2020;23(1):75–83.
  • Condi FLF, Soares JM, Teodoro WR, et al. The effects of conjugated estrogen, raloxifene and soy extract on collagen in rat bones. Climacteric. 2012;15(5):441–448.
  • Hong SE, Lee J, Seo DH, et al. Euphorbia factor L1 inhibits osteoclastogenesis by regulating cellular redox status and induces Fas-mediated apoptosis in osteoclast. Free Radic Biol Med. 2017;112:191–199.
  • Kvist TM, Syberg S, Petersen S, et al. The role of the P2X7 receptor on bone loss in a mouse model of inflammation-mediated osteoporosis. Bone Reports. 2017;7:145–151.
  • Polat B, Halici Z, Cadirci E, et al. The effect of alpha-lipoic acid in ovariectomy and inflammation-mediated osteoporosis on the skeletal status of rat bone. Eur J Pharmacol. 2013;718(1–3):469–474.
  • Zhang T, Li D, Wan L, et al. Ctenopharyngodon idella PERK (EIF2AK3) decreases cell viability by phosphorylating eIF2α under ER stress. Fish Shellfish Immunol. 2017;70:568–574.
  • Spehar Uroic A, Mulliqi Kotori V, Rojnic Putarek N, et al. Primary hypothyroidism and nipple hypoplasia in a girl with Wolcott-Rallison syndrome. Eur J Pediatr. 2014;173(4):529–531.
  • Wang R, Munoz EE, Zhu S, et al. Perk gene dosage regulates glucose homeostasis by modulating pancreatic β-cell functions. PLoS One. 2014;9(6):e99684.
  • Wei J, Sheng X, Feng D, et al. PERK is essential for neonatal skeletal development to regulate osteoblast proliferation and differentiation. J Cell Physiol. 2008;217(3):693–707.
  • Jahnavi S, Poovazhagi V, Kanthimathi S, et al. EIF2AK3 mutations in South Indian children with permanent neonatal diabetes mellitus associated with Wolcott-Rallison syndrome. Pediatr Diabetes. 2014;15(4):313–318.
  • Julier C, Nicolino M. Wolcott-Rallison syndrome. Orphanet J Rare Dis. 2010;5:29.
  • Zhang K, Wang M, Li Y, et al. The PERK-EIF2α-ATF4 signaling branch regulates osteoblast differentiation and proliferation by PTH . Am J Physiol Endocrinol Metab. 2019;316(4):E590–E604.
  • Guo J, Ren R, Sun K, et al. PERK controls bone homeostasis through the regulation of osteoclast differentiation and function. Cell Death & Disease. 2020;11(10):847.
  • Chang JS, Ocvirk S, Berger E, et al. Endoplasmic reticulum stress response promotes cytotoxic phenotype of CD8αβ+ intraepithelial lymphocytes in a mouse model for Crohn’s disease-like ileitis. J Immunol. 2012;189(3):1510–1520.
  • Lin W, Lin Y, Li J, et al. Oligodendrocyte-specific activation of PERK signaling protects mice against experimental autoimmune encephalomyelitis. J Neurosci. 2013;33(14):5980–5991.
  • Lin Y, Huang G, Jamison S, et al. PERK activation preserves the viability and function of remyelinating oligodendrocytes in immune-mediated demyelinating diseases. Am J Pathol. 2014;184(2):507–519.
  • Stockwell SR, Platt G, Barrie SE, et al. Mechanism-based screen for G1/S checkpoint activators identifies a selective activator of EIF2AK3/PERK signalling. PLoS One. 2012;7(1):e28568.
  • Bruch J, Xu H, Rosler TW, et al. PERK activation mitigates tau pathology in vitro and in vivo. EMBO Mol Med. 2017;9(3):371–384.
  • National Research Council. Guide for the care and use of laboratory animals. Washington (DC): National Academies Press; 2011.
  • Aydin A, Halici Z, Albayrak A, et al. Treatment with carnitine enhances bone fracture healing under osteoporotic and/or inflammatory conditions. Basic Clin Pharmacol Toxicol. 2015;117(3):173–179.
  • Schulte CM. Review article: bone disease in inflammatory bowel disease. Aliment Pharmacol Ther. 2004;20(4):43–49.
  • Smith BJ, Lerner MR, Bu SY, et al. Systemic bone loss and induction of coronary vessel disease in a rat model of chronic inflammation. Bone. 2006;38(3):378–386.
  • Romas E, Gillespie MT. Inflammation-induced bone loss: can it be prevented? Rheum Dis Clin North Am. 2006;32(4):759–773.
  • Zhang DW, Wang ZL, Qi W, et al. Cordycepin (3'-deoxyadenosine) down-regulates the proinflammatory cytokines in inflammation-induced osteoporosis model. Inflammation. 2014;37(4):1044–1049.
  • Zhu J, Li JH, Yuan TT, et al. Association between osteoporosis and severe periodontal attachment loss in postmenopausal women. Zhonghua Kou Qiang Yi Xue Za Zhi. 2020;55:159–164.
  • Duan P, Zhang J, Chen J, et al. Oolong tea drinking boosts calcaneus bone mineral density in postmenopausal women: a population-based study in southern China. Arch Osteoporos. 2020;15(1):49.
  • Liu J, Hoppman N, O’Connell JR, et al. A functional haplotype in EIF2AK3, an ER stress sensor, is associated with lower bone mineral density. J Bone Miner Res. 2012;27(2):331–341.
  • Tanaka K, Kaji H, Yamaguchi T, et al. Involvement of the osteoinductive factors, Tmem119 and BMP-2, and the ER stress response PERK-eIF2α-ATF4 pathway in the commitment of myoblastic into osteoblastic cells. Calcif Tissue Int. 2014;94(4):454–464.
  • Mastrangelo F, Quaresima R, Canullo L, et al. Effects of novel laser dental implant microtopography on human osteoblast proliferation and bone deposition. Int J Oral Maxillofac Implants. 2020;35(2):320–329.
  • Saito A, Ochiai K, Kondo S, et al. Endoplasmic reticulum stress response mediated by the PERK-eIF2(alpha)-ATF4 pathway is involved in osteoblast differentiation induced by BMP2. J Biol Chem. 2011;286(6):4809–4818.
  • Chen Y, Wang X, Yang H, et al. Upregulated expression of PERK in spinal ligament fibroblasts from the patients with ossification of the posterior longitudinal ligament. Eur Spine J. 2014;23(2):447–454.
  • Smieszek A, Marcinkowska K, Pielok A, et al. The role of miR-21 in osteoblasts-osteoclasts coupling in vitro. Cells. 2020;9(2):479.
  • Si J, Wang C, Zhang D, et al. Osteopontin in bone metabolism and bone diseases. Med Sci Monit. 2020;26:e919159.
  • Tasca A, Astleford K, Blixt NC, et al. SMAD1/5 signaling in osteoclasts regulates bone formation via coupling factors. PLoS One. 2018;13(9):e0203404.
  • Xia G, Wang J, Sun S, et al. Sialoglycoproteins prepared from the eggs of Carassius auratus prevent bone loss by inhibiting the NF-κB pathway in ovariectomized rats. Food Funct. 2016;7(2):704–712.
  • Sun P, Wang M, Yin GY. Endogenous parathyroid hormone (PTH) signals through osteoblasts via RANKL during fracture healing to affect osteoclasts. Biochem Biophys Res Commun. 2020;525(4):850–856.
  • Moon N, Effiong L, Song L, et al. Tart cherry prevents bone loss through inhibition of RANKL in TNF-overexpressing mice. Nutrients. 2018;11(1):63.
  • Wang TH, Jiang Y, Xiao LP. Expression of amyloid beta-protein in bone tissue of APP/PS1 transgenic mouse. Zhonghua Yi Xue Za Zhi. 2013;93:65–68.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.